Kosch M - Search Results

1

Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease.

Kosch M, Koch HG, Oliveira JP, Soares C, Bianco F, Breuning F, Rasmussen AK, Schaefer RM. Kosch M, et al. Kidney Int. 2004 Sep;66(3):1279-82. doi: 10.1111/j.1523-1755.2004.00883.x. Kidney Int. 2004. PMID: 15327428 Free article. Clinical Trial.

2

Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.

Kosch M, Barenbrock M, Suwelack B, Schaefer RM, Rahn KH, Hausberg M. Kosch M, et al. Am J Kidney Dis. 2003 May;41(5):1088-96. doi: 10.1016/s0272-6386(03)00207-5. Am J Kidney Dis. 2003. PMID: 12722044 Clinical Trial.

3

Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.

Kosch M, Levers A, Fobker M, Barenbrock M, Schaefer RM, Rahn KH, Hausberg M. Kosch M, et al. Nephrol Dial Transplant. 2003 Jul;18(7):1370-5. doi: 10.1093/ndt/gfg169. Nephrol Dial Transplant. 2003. PMID: 12808175 Clinical Trial.

4

[Indications and practical management of parenteral iron therapy].

Kosch M, Schaefer RM. Kosch M, et al. Wien Klin Wochenschr. 2003 Jun 24;115(11):380-4. doi: 10.1007/BF03040356. Wien Klin Wochenschr. 2003. PMID: 12879735 Review. German.

5

Folate metabolism in renal failure.

Teschner M, Kosch M, Schaefer RM. Teschner M, et al. Among authors: kosch m. Nephrol Dial Transplant. 2002;17 Suppl 5:24-7. doi: 10.1093/ndt/17.suppl_5.24. Nephrol Dial Transplant. 2002. PMID: 12091603 Review.

6

Sympathetic nerve activity in end-stage renal disease.

Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Hausberg M, et al. Among authors: kosch m. Circulation. 2002 Oct 8;106(15):1974-9. doi: 10.1161/01.cir.0000034043.16664.96. Circulation. 2002. PMID: 12370222 Clinical Trial.

7

Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation.

Barenbrock M, Kosch M, Jöster E, Kisters K, Rahn KH, Hausberg M. Barenbrock M, et al. Among authors: kosch m. J Hypertens. 2002 Jan;20(1):79-84. doi: 10.1097/00004872-200201000-00012. J Hypertens. 2002. PMID: 11791029

8

Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients.

Kosch M, Hausberg M, Suwelack B. Kosch M, et al. Transplantation. 2003 Nov 27;76(10):1516-9. doi: 10.1097/01.TP.0000092521.57633.BD. Transplantation. 2003. PMID: 14657697 Clinical Trial.

9

Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine.

Hausberg M, Lang D, Levers A, Suwelack B, Kisters K, Tokmak F, Barenbrock M, Kosch M. Hausberg M, et al. Among authors: kosch m. J Hypertens. 2006 May;24(5):957-64. doi: 10.1097/01.hjh.0000222767.15100.e4. J Hypertens. 2006. PMID: 16612259 Clinical Trial.

10

[Hypertension and diabetic nephropathy, a dangerous duo].

Hausberg M, Hohage H, Kosch M. Hausberg M, et al. Among authors: kosch m. Med Klin (Munich). 2005 Nov 15;100(11):729-37; quiz 738-9. doi: 10.1007/s00063-005-1103-4. Med Klin (Munich). 2005. PMID: 16328181 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page